HomeInsightsMarket Capitalization

Market Capitalization of Shilpa Medicare Ltd

Market Capitalization of Shilpa Medicare Ltd

stocks purchased

₹ 5.7 Cr

Volume transacted

stocks purchased

62.5 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Shilpa Medicare Ltd

NSE: SHILPAMED

MARKETCAP

8846.17 crore

Last updated: 18 Sep 24

Key Highlights

  • The Market Cap of Shilpa Medicare Ltd is ₹ 8846 crore as of 18 Sep 24.
  • The Market Cap of Shilpa Medicare Ltd changed from ₹ 2773 crore on March 2019 to ₹ 4004 crore on March 2024 . This represents a CAGR of 6.31% over 6 years. .
  • The Latest Trading Price of Shilpa Medicare Ltd is ₹ 904.6 as of 18 Sep 15:30.

Historical Market Cap of Shilpa Medicare Ltd

No data available

* All values are in crore

Company Fundamentals for Shilpa Medicare Ltd

No data available

Image

Shilpa Medicare Ltd

NSE: SHILPAMED

PRICE

904.6

12.80 (1.44%)

stock direction

Last updated: 18 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Shilpa Medicare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 2024904.6
17 Sep 2024891.8
16 Sep 2024894.4
13 Sep 2024883.05
12 Sep 2024892.6
11 Sep 2024877.5
10 Sep 2024843.45
09 Sep 2024831.9
06 Sep 2024808.65
05 Sep 2024829.35

SWOT Analysis Of Shilpa Medicare Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Shilpa Medicare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Shilpa Medicare Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Shilpa Medicare Ltd2158,846
Sun Pharmaceuticals Industries Ltd414,39,714
Divis Laboratories Ltd861,45,166
Cipla Ltd301,33,402
Torrent Pharmaceuticals Ltd681,13,724
Dr Reddys Laboratories Ltd191,09,604

Key Valuation Metric of Shilpa Medicare Ltd

No data available

Historical P/E Ratio of Shilpa Medicare Ltd

No data available

* All values are in %

Historical Revenue of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical EBITDA of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical Net Profit of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical Dividend Payout of Shilpa Medicare Ltd

No data available

* All values are in %

About Shilpa Medicare Ltd

  • Shilpa Medicare Limited (formerly known as Shilpa Antibiotics Limited) was incorporated as a Private Limited Company in November 20th, 1987 and has been promoted by Vishnukant C Bhutada and his associates.
  • Shilpa Medicare Limited (SML) is engaged in manufacturing of Active Pharmaceutical Ingredients (API), Formulation and Development service.
  • The Company started its operations as API manufacturer way back in 1987 at Raichur, Karnataka.
  • The company started commercial production in November 1989.
  • In November 1993, Shilpa Medicare Limited was converted into a Public Limited Company.

Shilpa Medicare Ltd News Hub

News

Shilpa Medicare update on its CDMO customer - Unicycive Therapeutics

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) announced the submission of NDA to U.S. FDA fo...

Read more

04 Sep 202415:14

News

Shilpa Medicare hits life high on submission of new drug application to USFDA

The said drug is used for treatment of hyperphosphatemia in patients with chronic kidney d...

Read more

04 Sep 202415:24

News

Shilpa Medicare hits record high on USFDA nod for cancer drug

The said product is the first liquid injection for Bortezomib, approved for both subcutane...

Read more

27 Aug 202414:43

News

Shilpa Medicare successfully completes phase-3 clinical studies of NorUDCA

Shilpa Medicare has successfully completed phase-3 clinical studies of its novel product S...

Read more

26 Aug 202410:30

News

Shilpa Medicare hits 52-week high on successful trial of fatty liver drug

NorUDCA is expected to revolutionise the treatment of patients suffering from Nonalcoholic...

Read more

26 Aug 202412:41

News

Shilpa Medicare to conduct AGM

Shilpa Medicare announced that the 37th Annual General Meeting (AGM) of the company will b...

Read more

16 Aug 202410:54

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Shilpa Medicare Ltd

What is the market cap of Shilpa Medicare Ltd?

As of September 18, 2024, Shilpa Medicare Ltd has a market capitalization of ₹8846.17, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Shilpa Medicare Ltd's market capitalization?

Shilpa Medicare Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Shilpa Medicare Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Shilpa Medicare Ltd's market capitalization change?

Shilpa Medicare Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*